期刊文献+

射频消融联合肝动脉化疗栓塞对HCC患者炎性、氧化应激反应及肿瘤活性因子指标影响 被引量:16

Effect of radiofrequency ablation combined with transcatheter arterial chemoembolization on inflammatory factors,oxidative stress response factors and tumor activity factors in patients with primary liver cancer
下载PDF
导出
摘要 目的:探讨射频消融(RFA)联合肝动脉化疗栓塞(TACE)对原发性肝癌(HCC)患者炎性因子、氧化应激反应因子及肿瘤活性因子指标的影响。方法:选择2014年1月~2016年6月100例原发性肝癌患者,随机分为观察组与对照组,各50例,其中观察组给予RFA联合TACE治疗,对照组单纯给予TACE治疗,比较两组治疗前(T0)及治疗1周(T1)、2周(T2)炎性因子、氧化应激反应因子及肿瘤活性因子指标。结果:(1)T1两组超敏C反应蛋白(hsCRP)、白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)水平呈明显增高,T2显著下降,T1>T1>T2,但观察组T1hs-CRP、IL-6、TNF-α水平高于对照组,差异有统计学意义(hs-CRPt_(T1)=22.135,IL-6t_(T1)=101.446,TNF-αt_(T1)=131.055,P<0.05),T2两组hsCRP、IL-6、TNF-α水平差异无统计学意义(hs-CRPt_(T2)=5.856,IL-6t_(T2)=2.461,TNF-αt_(T2)=2.584,P>0.05);(2)T1观察组活性氧(ROS)水平高于对照组,超氧化物歧化酶(SOD)与总抗氧化能力(T-AOC)水平低于对照组;T2观察组ROS水平低于对照组,SOD、T-AOC水平高于对照组,差异有显著统计学意义(ROSt_(T1)=136.137,SODt_(T2)=81.352,T-AOCt_(T1)=11.065,ROSt_(T2)=95.185,SODt_(T1)=109.124,T-AOCt_(T2)=26.987,P<0.05)。(3)观察组T1、T2血清甲胎蛋白(AFP)、糖类抗原CA199、基质金属蛋白酶(MMP)水平低于对照组,差异有统计学意义(AFPt_(T1)=263.754,CA199t_(T1)=112.342,MMPt_(T1)=45.675,AFPt_(T2)=86.764,CA199t_(T2)=42.376,MMPt_(T2)=37.352,P<0.05)。结论:RFA治疗HCC尽管早期有导致机体炎症状态和氧化应激加剧的现象,但其联合TACE治疗HCC可有效改善机体微炎症状态,特别是能提高机体抗氧化功能,降低肿瘤活性因子水平。 Objective:To investigate the effects of radiofrequency ablation(RFA)combined with transcatheter arterial chemoembolization(TACE)on inflammatory factors,oxidative stress response factors and tumor activity factors in primary hepatocellular carcinoma(HCC)patients.Methods:A total of 100 cases of primary liver cancer patients from January 2014 to June 2016 were selected and randomly divided into observation group and control group with 50 cases in each group,the observation group was treated with RFA combined with TACE treatment,the control group was given TACE treatment,compared two groups before treatment(T0),1weeks of treatment(T1),2weeks(T2)inflammation factor,oxidative stress factor and tumor activity index.Results:1 The hs-CRP,IL-6and TNF-αlevels of T1 in two groups were significantly increased,T2 decreased ignificantly,T1〉 T1〉 T2,but the observation group hs-CRP,IL-6,TNF-αlevels of T1 were higher than the control group and the difference was statistically significant(hs-CRPt(T1)=22.135,IL-6t(T1)=101.446,TNF-αt(T1)=131.055,P〈0.05),hs-CRP,IL-6,TNF-αlevels of T2 had no statistically significant(hs-CRPt(T2)=5.856,IL-6t(T2)=2.461,TNF-αt(T2)=2.584,P〉0.05);2 The ROS level of T1 in the observation group was higher than the control group,while the SOD and TAOC levels were lower than the control group,the ROS level of T2 in the observation group was lower than the control group,SOD and T-AOCwere higher than the control group,there was significant difference(ROSt(T1)=136.137,SODt(T2)=81.352,T-AOCt(T1)=11.065.ROSt(T2)=95.185,SODt(T1)=109.124,T-AOCt(T2)=26.987,P〈0.05).3Serum AFP,CA199 and MMP levels in T1 and T2of the observation group were lower than the control group,the difference was statistically significant(AFPt(T1)=263.754,CA199 t(T1)=112.342,MMPt(T1)=45.675,AFPt(T2)=86.764,CA199 t(T2)=42.376,MMPt(T2)=37.352,P〈0.05).Conclusions:RFA treatment of HCC may lead to inflammation and increased oxidative stress in the early stage.However,TACE combined with TACE can improve the microinflammatory state,especially enhance the antioxidant function and decrease the level of tumor active factor.
作者 杨昆 王学文 赖钊 邱桂刚 杨森 YANG Kun WANG Xue-wen LAI Zhao QIU Gui-gang YANG Sen(Department of Hepatobiliary Surgery, the Forth People's Hospital of Zigong City, Zigong City 643000 Sichuan Province, Chin)
出处 《海南医学院学报》 CAS 2017年第4期531-534,538,共5页 Journal of Hainan Medical University
基金 四川省技术创新资助项目(2014CY01359)~~
关键词 射频消融 肝动脉化疗栓塞 原发性肝癌 炎性因子 氧化应激 肿瘤活性因子 Radiofrequency ablation Transcatheter arterial chemoembolization Primary liver cancer Inflammatory cytokines Oxidative stress Tumor activity factor
  • 相关文献

参考文献10

二级参考文献77

  • 1张伟杰,杨甲梅.原发性肝癌合并门静脉癌栓的治疗现状[J].肝胆外科杂志,2005,13(4):314-316. 被引量:24
  • 2崔林,吴兴军,余扬群,张志胜,路逵,刘建军,薛存珍,刘兴祥,柯军.经皮肝穿刺门静脉化疗栓塞治疗原发性肝癌门静脉癌栓[J].中国癌症杂志,2005,15(4):381-382. 被引量:11
  • 3李坚,王洪林,陈翔,王济明,郑军,闫雄.含奥沙利铂方案介入治疗中晚期肝癌的疗效观察[J].重庆医学,2005,34(9):1371-1372. 被引量:6
  • 4周宏平,冯志洪,赵峰,薛青萍,杨玉芝.高强度聚焦超声治疗门静脉栓塞临床研究[J].徐州医学院学报,2007,27(8):550-553. 被引量:2
  • 5Shi J, l,ai EC. l.i N, et al. A new classification lbr hepalovelhdar t'arcinoma with portal vein tu,nor Ih,'~unhus [Jl. J Hepalobiliar Pancr Sci. 201 h 18: 74-80.
  • 6Schwallz Jl), Schwartz M. Mandeli J, et al. Neoadjuvant and adjuvant therapy fiw resectable hepatocellular carcinoma: review of the randomised clinical trials[J]. 1.ancet Oncol. 2002, 3: 593- 603.
  • 7Biolato M, Marrome G, Racco S, et al. Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins?[J]. Eur Rev Med Pharmacol Sci, 2010, 14: 356-362.
  • 8Hashem B. El-Serag.Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma[J]. Gastroenterology . 2012 (6)
  • 9Bruix J,Sherman M.Management of hepatocellular carcinoma. Hepatology . 2005
  • 10Mazzaferro V,Regalia E,Doci R,et al.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New England Journal of Medicine, The . 1996

共引文献1211

同被引文献173

引证文献16

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部